Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Korean Journal of Psychopharmacology
>
>
18
Volume:
18
1. Hyponatremia with Neurological Symptom in Patients with Chronic Schizophrenia : Five Cases.
Page:110—117
2. Body Mass Index(BMI) Changes during Combination Therapy with Mood Stabilizers and Antipsychotics in Acute Mania.
Page:103—109
3. Body Weight Gain and Metabolic Changes in Patients with Schizophrenia during 12-Week Randomized Treatment of Ziprasidone and Risperidone.
Page:92—102
4. Two-Year Rehospitalization Rates of First Episode Schizophrenic Inpatients Discharged on Antipsychotic Medication : A Preliminary Study.
Page:86—91
5. Assessment of Abdominal Fat and Mid-Thigh Low-Density Muscle Areas in Patients with Schizophrenia.
Page:81—85
6. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(II): Initial Treatment and Treatment Resistant OCD.
Page:347—357
7. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007 (I).
Page:338—346
8. Maintenance Period of Venlafaxine ER Treatment in Patients Having Major Depressive Disorder with Somatic Symptoms.
Page:329—337
9. Risperidone Combination in the Acute Treatment of Bipolar Mania and Mixed Episode: Prospective, Multicenter, Open Trial.
Page:318—328
10. A Case of Single Photon Emission Computerized Tomographic Finding in Patient with Acquired Deafness and Musical Hallucinosis after Viral Encephalitis.
Page:60—64
11. Prescription Status and Efficacy of OROS-MPH and Parent Perception in Children with Attention Deficit Hyperactivity Disorder : Multi-Center, Observational Study during 4 Weeks.
Page:50—59
12. Multicenter Clinical Trials for Efficacy and Safety of Mirtazapine in Moderate-to-Severe Major Depressive Patients.
Page:36—49
13. Do SSRIs Really Induce Suicidal Behavior? : The Critical Review of Evidences.
Page:25—35
14. Intravenous Anti-obsessive Agents : A Review.
Page:18—24
15. Korean Traditional Medicines as Novel Drugs for Neuropsychiatric Disorders.
Page:5—17
16. Comparison of the Clinical Efficacy and Safety between Intramuscular Olanzapine and Intramuscular Haloperidol Injection in the Treatment of Delirium.
Page:423—428
17. Comparison of the Clinical Efficacy and Safety between Intramuscular Olanzapine and Intramuscular Haloperidol Injection in the Treatment of Delirium.
Page:423—428
18. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(IV): Comorbid Conditions.
Page:414—422
19. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(IV): Comorbid Conditions.
Page:414—422
20. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(III): A Preliminary Study for Application of Cognitive-Behavioral Therapy.
Page:408—413
21. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(III): A Preliminary Study for Application of Cognitive-Behavioral Therapy.
Page:408—413
22. Changes of Medication Usage in Inpatients with Major Depressive Disorder: One University Hospital between Year 2001 and 2006.
Page:399—407
23. Changes of Medication Usage in Inpatients with Major Depressive Disorder: One University Hospital between Year 2001 and 2006.
Page:399—407
24. The Association between Smoking and Depression.
Page:393—398
25. The Association between Smoking and Depression.
Page:393—398
26. Atypical Antipsychotics in Bipolar Depression: Neurobiological Mechanisms and Application to Treatment.
Page:384—392
27. The Implication of Incrementally Modified Drug Technology and the Current Trends in Psychopharmacology.
Page:373—383
28. Atypical Antipsychotics in Bipolar Depression: Neurobiological Mechanisms and Application to Treatment.
Page:384—392
29. The Implication of Incrementally Modified Drug Technology and the Current Trends in Psychopharmacology.
Page:373—383
30. Ziprasidone Induced Neutropenia.
Page:251—255
31. Elevation of Serum Creatine Kinase Level in a Patient Treated with Atypical Antipsychotics: A Case Report.
Page:246—250
32. Comparison of Efficacy between Aripiprazole and Haloperidol in the Treatment of Patients with Delirium.
Page:240—245
33. Remission Rates and Criteria for Clinical Studies on Schizophrenia.
Page:231—239
34. A Validation Study of the Korean Version of the Subjective Well-being Under Neuroleptic Treatment Scale-Short Form.
Page:221—230
35. Common Gene Expression Pattern in the Rat Brain Induced by Several Mood: Stabilizing Drugs.
Page:211—220
36. Brain Mapping for Memory and Learning.
Page:199—210
37. Recent 5-Year Trends of Prescription Patterns in Inpatients with Bipolar Disorder in Four Hospitals.
Page:308—317
38. The Relationship between the Antipsychotics-Induced Weight Gain and the Dopamine D2, D3, and D4 Receptor Gene Polymorphisms in Korean Schizophrenic Patients.
Page:299—307
39. Effects of Haloperidol on Ca2+i Change in HIT T-15 Insulinoma Cells.
Page:288—298
40. Neurokinin and Its Receptors: Association with Learning and Memory.
Page:280—287
41. Role of 5-HT1A Receptors in Learning and Memory.
Page:271—279
42. Rhabdomyolysis Associated with Ziprasidone.
Page:181—184
43. Treatment of Persistent Hiccups with Risperidone Quicklet.
Page:177—180
44. A Case of Aggressive and Violent Patient with Treatment-Resistant Schizophrenia Treated with Long-Acting Injectable Risperidone.
Page:171—176
45. Clinical Efficacy and Safety of Memantine in Patients with Moderate to Severe Dementia.
Page:163—170
46. The Subjective Effect of Quetiapine Monotherapy on Sleep and Daytime Sleepiness in Acute Manic Patient.
Page:152—162
47. Association of BDNF Val66Met Polymorphism with Depressive and Cognitive Symptoms in Patients with Schizophrenia.
Page:143—151
48. Neuroanatomy of Sleep-Wake Regulation and its Application to Pharmacotherapy.
Page:133—142